Search Results - "PRIOLO, Carmen"

Refine Results
  1. 1

    AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer by Priolo, Carmen, Pyne, Saumyadipta, Rose, Joshua, Regan, Erzsébet Ravasz, Zadra, Giorgia, Photopoulos, Cornelia, Cacciatore, Stefano, Schultz, Denise, Scaglia, Natalia, McDunn, Jonathan, De Marzo, Angelo M, Loda, Massimo

    Published in Cancer research (Chicago, Ill.) (15-12-2014)
    “…Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor pathways that affect their metabolism, or by activating…”
    Get full text
    Journal Article
  2. 2

    A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis by Zadra, Giorgia, Photopoulos, Cornelia, Tyekucheva, Svitlana, Heidari, Pedram, Weng, Qing Ping, Fedele, Giuseppe, Liu, Hong, Scaglia, Natalia, Priolo, Carmen, Sicinska, Ewa, Mahmood, Umar, Signoretti, Sabina, Birnberg, Neal, Loda, Massimo

    Published in EMBO molecular medicine (01-04-2014)
    “…5′AMP‐activated kinase (AMPK) constitutes a hub for cellular metabolic and growth control, thus representing an ideal therapeutic target for prostate cancers…”
    Get full text
    Journal Article
  3. 3
  4. 4

    New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK by ZADRA, Giorgia, PRIOLO, Carmen, PATNAIK, Akash, LODA, Massimo

    Published in Clinical cancer research (01-07-2010)
    “…Although the role of metabolic syndrome (MS) and a high fat diet in prostate cancer (PCa) risk is still a matter of intense debate, it is becoming increasingly…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Plasma metabolomics and clinical predictors of survival differences in COPD patients by Pinto-Plata, Victor, Casanova, Ciro, Divo, Miguel, Tesfaigzi, Yohannes, Calhoun, Vince, Sui, Jing, Polverino, Francesca, Priolo, Carmen, Petersen, Hans, de Torres, Juan Pablo, Marin, Jose Maria, Owen, Caroline A, Baz, Rebeca, Cordova, Elizabeth, Celli, Bartolome

    Published in Respiratory research (15-10-2019)
    “…Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP's relationship to survival has not been reported. We…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways by Stump, Benjamin, Shrestha, Shikshya, Lamattina, Anthony M, Louis, Pierce H, Cho, Woohyun, Perrella, Mark A, Ai, Xingbin, Rosas, Ivan O, Wagner, Florence F, Priolo, Carmen, Astin, Jonathan, El-Chemaly, Souheil

    Published in PloS one (09-04-2019)
    “…Lymphatic vessels play an important role in health and in disease. In this study, we evaluated the effects of GSK3-β inhibition on lung lymphatic endothelial…”
    Get full text
    Journal Article
  9. 9

    Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis by Priolo, Carmen, Ricoult, Stéphane J H, Khabibullin, Damir, Filippakis, Harilaos, Yu, Jane, Manning, Brendan D, Clish, Clary, Henske, Elizabeth P

    “…Lymphangioleiomyomatosis (LAM) is a destructive lung disease affecting women. LAM is caused by mutations in the tuberous sclerosis complex (TSC) genes. The TSC…”
    Get full text
    Journal Article
  10. 10

    MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM) by Trindade, Anil J, Medvetz, Douglas A, Neuman, Nicole A, Myachina, Faina, Yu, Jane, Priolo, Carmen, Henske, Elizabeth P

    Published in PloS one (29-03-2013)
    “…Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of smooth muscle-like cells in the lung resulting in cystic…”
    Get full text
    Journal Article
  11. 11

    The isopeptidase USP2a protects human prostate cancer from apoptosis by PRIOLO, Carmen, DAN TANG, FEBBO, Phillip, LODA, Massimo, BRAHAMANDAN, Mohan, BENASSI, Barbara, SICINSKA, Ewa, OGINO, Shuji, FARSETTI, Antonella, PORRELLO, Alessandro, FINN, Stephen, ZIMMERMANN, Johann

    Published in Cancer research (Chicago, Ill.) (01-09-2006)
    “…Deubiquitinating enzymes can prevent the destruction of protein substrates prior to proteasomal degradation. The ubiquitin-specific protease 2a (USP2a)…”
    Get full text
    Journal Article
  12. 12

    Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors by Priolo, Carmen, Agostini, Michelle, Vena, Natalie, Ligon, Azra H, Fiorentino, Michelangelo, Shin, Eyoung, Farsetti, Antonella, Pontecorvi, Alfredo, Sicinska, Ewa, Loda, Massimo

    Published in The American journal of pathology (01-04-2010)
    “…Serum prostate-specific antigen screening has led to earlier detection and surgical treatment of prostate cancer, favoring an increasing incidence-to-mortality…”
    Get full text
    Journal Article
  13. 13

    FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma by NUCERA, Carmelo, EECKHOUTE, Jerome, PONTECORVI, Alfredo, NOSE, Vania, LODA, Massimo, BROWN, Myles, FINN, Stephen, CARROLL, Jason S, LIGON, Azra H, PRIOLO, Carmen, FADDA, Guido, TONER, Mary, SHEILS, Orla, ATTARD, Marco

    Published in Clinical cancer research (01-06-2009)
    “…Purpose: FOXA1 is a mammalian endodermal transcription factor belonging to the human forkhead box gene family that plays a role in certain tumor types. Here,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    52 Ferroptosis Suppressor Protein 1 is a Potent and Targetable Inhibitor of Ferroptosis in Chromophobe Renal Cell by Salem, Samer, Mahmoud, Nadine, Chami, Joelle, Alchoueiry, Michel, Daou, Melissa, Mansour, Hadi, Khabibullin, Damir, Priolo, Carmen, Henske, Elizabeth

    Published in The oncologist (Dayton, Ohio) (06-08-2024)
    “…Abstract Background There are currently no proven therapies for metastatic or unresectable Chromophobe renal cell carcinoma (ChRCC). Ferroptosis is an…”
    Get full text
    Journal Article
  20. 20

    Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift by Medvetz, Doug, Priolo, Carmen, Henske, Elizabeth P

    Published in Molecular cancer research (01-01-2015)
    “…mTORC1 is an established master regulator of cellular metabolic homeostasis, via multiple mechanisms that include altered glucose and glutamine metabolism, and…”
    Get full text
    Journal Article